Steele, C.W., Jamieson, N.B., Evans, T.R., McKay, C.J., Sansom, O.J. and Morton, J.P. (2013) Exploiting Inflammation for Therapeutic Gain in Pancreatic Cancer. British Journal of Cancer, 108, 997-1003.
https://doi.org/10.1038/bjc.2013.24

has been cited by the following article:

• TITLE: Role of Probiotics in Pancreatic Cancer Prevention: The Prospects and Challenges

  AUTHORS: Barkha Singhal, Ankita Mukherjee, Shubham Srivastav

  KEYWORDS: Gut Microbiota, Immunomodulation, Lifestyle Diseases, Probiotics, Pancreatic Cancer, Pancreatitis

  JOURNAL NAME: Advances in Bioscience and Biotechnology, Vol.7 No.11, November 30, 2016

  ABSTRACT: Pancreatic cancer is expressed as a disorder of chaos that leads to impairment in biochemical and metabolic physiology of pancreas. It is considered as the most intractable and fatal among all gastrointestinal (GI) cancers. The early occurrence of metastatic spread and the development of intrinsic and acquired resistance during drug treatment limit its prognosis at the right time. The universalized treatment involves surgical resection in which only a minority (in vitro, animal and clinical studies are required for worthy manifestations.